Bemærk: Kan ikke leveres før jul.
Forventes på lager: 17-03-2024
Novel drugs and disease targets have changed the way developers and regulatory agencies think about clinical trial methodology.The book elucidates how biomarkers, genetics and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry.
| Forlag | Springer International Publishing AG |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | 2023 ed. |
| Udgivelsesdato | 17-03-2024 |
| Første udgivelsesår | 2024 |
| Serie | Advances in Neurobiology |
| Illustrationer | 18 Illustrations, color; 25 Illustrations, black and white; VIII, 459 p. 43 illus., 18 illus. in color. |
| Fagredaktør | Matthew Macaluso, Sheldon H. Preskorn, Richard C. Shelton |
| Originalsprog | Switzerland |
| Sideantal | 459 |
| Indbinding | Paperback / softback |
| Forlag | Springer International Publishing AG |
| Sideoplysninger | 459 pages, 18 Illustrations, color; 25 Illustrations, black and white; VIII, 459 p. 43 illus., 18 il |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783031210563 |